Probenecid‐Boosted Tenofovir: A PBPK Model Informed Strategy for On‐demand HIV Pre‐exposure Prophylaxis

CPT: Pharmacometrics and Systems Pharmacology - United States
doi 10.1002/psp4.12481
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Tenofovir-Based Pre-Exposure Prophylaxis for HIV Prevention

Current Opinion in Infectious Diseases
Infectious DiseasesMicrobiology
2012English

HIV Pre-Exposure Prophylaxis

CMAJ
Medicine
2014English

The Safety of Tenofovir-Emtricitabine for HIV Pre-Exposure Prophylaxis (PrEP) in Individuals With Active Hepatitis B.

Journal of Acquired Immune Deficiency Syndromes
Infectious DiseasesPharmacology
2016English

Canadian Guideline on HIV Pre-Exposure Prophylaxis and Nonoccupational Postexposure Prophylaxis

CMAJ
Medicine
2018English

Comparing Pharmacologic Measures of Tenofovir Exposure in a U.S. Pre-Exposure Prophylaxis Randomized Trial

PLoS ONE
Multidisciplinary
2018English

Tenofovir Pre-Exposure Prophylaxis for Pregnant and Breastfeeding Women at Risk of HIV Infection: The Time Is Now

PLoS Medicine
BiochemistryBiotechnologyMolecular BiologyCell BiologyMedicine
2016English

HIV Pre-Exposure Prophylaxis (PrEP): Effective but Controversial

Trends in Urology & Men's Health
2017English

Pre-Exposure Prophylaxis for HIV Prevention in Women: Current Perspectives

International Journal of Women's Health
GynecologyOncologyMidwiferyMaternityObstetrics
2017English

HIV Pre-Exposure Prophylaxis in South East Asia: A Focused Review on Present Situation

International Journal of Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy